Abstract. Podocytes serve a critical role in the development of many glomerular diseases, including diabetic nephropathy (DN). Epigallocatechin-3-gallate (EGCG), a predominant polyphenolic component of green tea, has indicated its therapeutic effects in diabetes. In the present study, mouse podocyte cells were cultured in vitro, cell injury was induced by high glucose, and the protective effect of EGCG on cell proliferation and apoptosis and the underlying mechanisms were investigated. The results demonstrated that high glucose significantly inhibited cell proliferation after 48 and 72 h compared with normal glucose and mannitol treatment. EGCG (20 µmol/l) markedly promoted podocyte proliferation after 24, 48 and 72 h incubation with high glucose. Furthermore, high glucose significantly reduced WT-1 and nephrin expression in podocytes compared with the normal glucose and mannitol groups, while EGCG (20 µmol/l) treatment largely restored their expression. High glucose also significantly increased the apoptotic cell population compared with normal glucose and mannitol groups. However, EGCG combined with high glucose greatly decreased the apoptotic cell number compared with high glucose treatment alone. Furthermore, high glucose treatment was demonstrated to significantly increase glucose-regulated protein 78 (GRP78), phosphorylated-PKR-like ER kinase (p-PERK) and caspase-12 protein expression levels, which is representative of endoplasmic reticulum (ER) stress, compared with the normal glucose and mannitol groups. However, EGCG treatment significantly attenuated GRP78, p-PERK and caspase-12 protein expression induced by high glucose. These findings suggested that EGCG serves a protective role in glucose-induced podocyte apoptosis via suppressing ER stress, and may provide a novel therapeutic strategy to ameliorate the process of DN.
Introduction
Diabetic nephropathy (DN) is one of most serious complications of both type 1 and type 2 diabetes, and frequently results in end-stage renal disease (ESRD), which eventually requires renal replacement therapy or renal transplantation (1) . Initiation and development of DN is closely associated with podocyte injury and loss, and involved mechanisms include podocyte apoptosis, detachment, hypertrophy, effacement and loss of foot process proteins (2) (3) (4) (5) . Among them, podocyte apoptosis is a hotspot of research. Increasing data has that revealed endoplasmic reticulum (ER) stress serves an important role in the podocyte apoptosis (6, 7) . It is understood that ER stress is a kind of adaptive response of the cell itself. Under normal physiological conditions, aggregated protein does not amass in cells partially due to the presence of cellular 'quality control' mechanisms (8) . However, the unfolded protein response (UPR), whose role is restoring ER homeostasis and normal function, will activate a series of signaling molecules and induce the apoptosis cascade when the ER is exposed in a harmful environment for an extended period of time (9, 10) . The UPR is characterized by the activation of three ER transmembrane effector proteins: PKR-like ER kinase (PERK), inositol requiring enzyme 1 (IRE1) and activating transcription factor-6 (ATF-6) (11) . One major pathway of UPR is the suppression of most protein translations through phosphorylation of eukaryotic translation initiation factor 2 subunit a (eIf2a) by PERK (12) . Another pathway is the upregulated expression of ER-localized molecular chaperones, such as glucose-regulated protein 78 (GRP78/Bip), GRP94 and other molecular chaperones like heat shock proteins (13) . After a series of target protein activation, activation of ER resident protein caspase-12 will eventually lead to the cellular apoptosis (14) .
Epigallocatechin-3-gallate (EGCG), the most abundant catechin in green tea, has been demonstrated to exert its anti-inflammatory, antioxidant and antitumor properties in chronic diseases including cancer (15, 16) , neurodegenerative disease (17) , diabetes (18) , heart disease (19) and autoimmune arthritis (20) . EGCG can prevent DN progression through decreasing reactive oxygen species (ROS) expression (21) . However, the concrete mechanism of EGCG on high glucose-induced podocyte injury remains uncertain. The current study aimed to investigate the effects of EGCG on proliferation and apoptosis of mouse podocytes cultured in Epigallocatechin-3-gallate protects from high glucose induced podocyte apoptosis via suppressing endoplasmic reticulum stress high glucose, and to provide a theoretical basis of the mechanisms involved in ER stress.
Materials and methods
Cell culture. The conditionally immortalized mouse podocytes donated by Dr Peter Mundel (Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA) were maintained in RPMI1640 medium supplemented with 10% fetal bovine serum (Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA), 10 U/ml interferon-γ (PeproTech, Inc., Rocky Hill, NJ, USA) and 100 U/ml antibiotics (penicillin and streptomycin). Frozen podocytes were firstly cultivated at 33˚C in a 5% CO 2 incubator. Then cells were cultured in medium at 37˚C without interferon-γ to induce differentiation for at least 2 weeks. Cells were cultured in serum-free medium for 24 h to synchronize the cell growth before each experiment.
Cell viability assay. Podocytes were seeded at a density of 1x10^4 cells per well in 100 ul RPMI1640 complete medium on 96-well plates for 24 h. Cells were divided into 10 groups as follows: 5. Podocyte injury and apoptosis. Cells of 4 groups (N, M, H and E20) in the above conditions were used for the following experiments. Mouse podocytes were inoculated at a density of 1x10 5 cells/well on cover slides in six-well plates. Then cells were washed with phosphate buffer saline (PBS) and incubated with 0.1% Triton X-100 at room temperature for 5 min. Hoechst 33258 (Sigma-Aldrich; Merck KGaA) was added on the cells and incubated in the dark for 20 min. Images were captured under a fluorescence microscope (Olympus DP72, Olympus Corporation, Tokyo, Japan).
Flow cytometry. Cells were selected for planting in the petri dishes with treatment of normal glucose, mannitol, high glucose or high glucose with 20 µmol/l EGCG. Cells were collected after 72 h and the cell concentration was adjusted to 1x10^6 in 500 µl binding buffer (BD Biosciences). Annexin V-fluorescein isothiocyanate (5 µl) and propidium iodide (PI; 10 µl) were added into each sample and incubated at 37˚C for 30 min without bright light. The apoptosis data was acquired by a flow cytometer (Epics XL, Beckman Coulter, Inc., Kreefeld, Germany).
Western blotting. Cells were treated with different conditions and then lysed in radioimmunoprecipitation buffer containing protease inhibitor. After centrifugation at 24,000 x g and 4˚C for 30 min, supernatants were collected and analyzed for protein concentration with a Bicinchoninic Acid protein assay kit (Beyotime Institute of Biotechnology, Shanghai, China). Total protein (30-50 µg) was diluted in sample buffer and boiled for 5 min for denaturation. Proteins in each sample were separated by 10% SDS-PAGE and transferred to a nitrocellulose filter membrane. After blocking with 5% milk in PBS with Tween-20 for 1 h, the membrane was incubated at 4˚C overnight with the following primary antibodies: Anti-GAPDH (1:1,000; cat. no. ab9485), anti-Nephrin (1:1,000; cat. no. ab136894), anti-Wilms tumor protein 1 (WT-1; 1:1,000; cat. no. ab180840), anti-GRP78 (1:2,000; cat. no. ab21685), anti-caspase-12 (1:2,000; cat. no. ab62484) (all from Abcam, Cambridge, UK), anti-PERK (1:1,000; cat. no. sc-13073) and anti-phosphorylated (p)-PERK (1:1,000; cat. no. sc-32577) (both from Santa Cruz Biotechnology, Inc., Dallas, TX, USA). The membranes were washed and incubated with a goat anti-rabbit horseradish peroxidase-conjugated IgG secondary antibody (1:5,000; cat. no. ZB-2301, Origene Technologies, Inc., Rockville, MD, USA) at 24˚C for 1 h. Protein expression was detected with a chemiluminescence detection kit (EMD Millipore, Billerica, MA, USA). Data were analyzed using a western-blot analyzer (FluorChen E ProteinSimple Inc., San Jose, CA, USA).
Statistical analysis. All data are expressed as the mean ± standard deviation. Data were analyzed using SPSS 18.0 software (SPSS Inc., Chicago, IL, USA). Data were analyzed by one-way analysis variance followed by Dunnett's multiple comparison test. P<0.05 was considered to indicate a statistically significant difference.
Results
EGCG promotes podocyte proliferation. Cells were cultured with normal glucose (N), D-mannitol (M) and high glucose (H) for 24, 48 and 72 h, respectively. CCK-8 reagent was used to detect podocyte proliferation. Optical density 450 values were used to represent cell proliferation. D-mannitol was used to observe the influence of hypertonicity on cells. As presented in Fig. 1A , there was no difference in cell proliferation among groups when cells were incubated for 24 h (P>0.05). Cell proliferation in H group was significantly decreased compared with N and M groups when cells were incubated for 48 or 72 h (P<0.05). There were no significant differences between N and M group. Interestingly, when EGCG with different concentrations was added to high glucose treated cells, EGCG especially at a concentration of 20 µmol/l (E20) significantly promoted cell proliferation (P<0.01, Fig. 1B) . However, its effect gradually decreased with increasing EGCG concentration (Fig. 1B) .
EGCG attenuates high glucose-induced podocyte injury.
WT-1 and nephrin are well-known podocyte-specific protein markers and thus are used to evaluate podocyte damage. It was demonstrated that both WT-1 and nephrin protein expression levels were decreased in podocytes stimulated with high glucose compared with those with normal glucose or mannitol (P<0.05, Fig. 2 ). However, this significantly increased following treatment of EGCG (20 µmol/l) and high glucose, compared with high glucose alone (P<0.05; Fig. 2 ).
EGCG reduces podocyte apoptosis induced by high glucose.
Cells under different conditions were cultured for 72 h and cell apoptosis was analyzed by flow cytometry. There was little population of apoptotic cells in either the N (0.36%) and M (0.42%) groups, but the apoptotic population significantly increased in the high glucose group (7.1%) compared with the normal and mannitol groups (P<0.05, Fig. 3A) . As predicted, EGCG (20 µmol/l) treatment in high glucose incubated cells significantly reduced the apoptotic cell population percentage (3.24%; P<0.05; Fig. 3A and B) .
In order to identify apoptotic cells, Hoechst 33258 was used for staining cell nuclear to detect cell apoptosis. In the H group, there were significantly more typical apoptotic cells, in which the nuclear shape became petals or nucleolus pyknosised, compared with the N and M groups (Fig. 3C) . EGCG (20 µmol/l) greatly decreased the number of apoptotic cells treated with high glucose (P<0.05; Fig. 3D ).
EGCG attenuates GRP78, p-PERK and caspase-12 expression after high glucose stimulation.
To investigate whether EGCG protects against high glucose-induced podocyte injury via ER stress signaling, the expression of ER stress-associated markers, GRP78, p-PERK and caspase-12, were assessed. After high glucose stimulation, GRP78, p-PERK and caspase-12 were significantly increased compared with the normal glucose and mannitol groups (P<0.05; Fig. 4) . However, these protein expression levels were markedly attenuated after EGCG (20 µmol/l) treatment (P<0.05; Fig. 4) .
Discussion
Podocytes are a type of highly differentiated and non-renewable glomerular epithelial cell (22) . It is generally accepted that the loss and apoptosis of podocytes which occur at an early stage of DN are closely associated with its progression, and is a main cause of proteinuria and glomerulosclerosis development (23) . Previous studies have demonstrated that EGCG treatment can attenuate ischemia/reperfusion-induced renal dysfunction though inhibition of proinflammatory cytokine cell apoptosis (24) , and protect against cisplatin-induced nephrotoxicity via suppression of ER stress-induced (25) and mitochondrial dependent apoptotic pathways (26) . The results of the present study demonstrated that EGCG is able to promote high-glucose induced podocyte proliferation and can also suppress high-glucose induced cell apoptosis of podocytes.
The ER serves an important role in adaptation of cell alterations under different conditions. It has been demonstrated that numerous factors, including free oxygen, immoderate nutrients, high glucose and free fatty acids, all can initiate apoptosis and generate ER stress and tissue damage (27) . Podocyte loss in DN may be associated with ER stress-induced apoptosis (28, 29) . High glucose can lead to cell injury and trigger ER stress in podocytes (28) . GRP78, the first response protein and one of the main modulators of the UPR, has been generally implicated as a marker for the initiation of ER stress (30, 31) . GRP78 combines with the N-termini of transmembrane ER proteins to prevent protein aggregation under normal conditions. When unfolded proteins amass, GRP78 is released and the vital transmembrane ER signaling proteins, including PERK, IRE1 and ATF6, are triggered to launch ER stress (31, 32) . PERK cleaves from GRP78, inducing its autophosphorylation through oligomerization to further phosphorylate the α subunit of translation initiation factor 2 (eIF2α) to trigger ER stress (27) . Thus, GRP78 serves a fundamental role in identification of unfolded proteins. Caspase-12, unlike other caspases, is specifically located in the cytoplasm of the ER and can be activated during ER stress but not through mitochondrial signals and other death stimuli (14) . Upon caspase-12 activation, it can directly enter cytosol and process with downstream caspase family mainly including caspase-3, which leads to cell apoptosis (31) . GRP78 is an inductor of ER stress and caspase-12 is an executor of ER stress-induced apoptosis. The current study indicates that ER stress is activated by high glucose, and protein expression of GRP78, p-PERK and caspase-12 are upregulated. EGCG treatment can reduce high glucose-induced ER stress. All the results suggest that EGCG may protect from podocyte apoptosis via suppression of ER stress pathway. A schematic representation of EGCG protection against podocyte apoptosis from high glucose stimulation, via ER stress signaling, is presented in Fig. 5 . . Hypothetical schematic of EGCG protection against podocyte apoptosis from high glucose stimulation through ER stress signaling. ER, endoplasmic reticulum; p, phosphorylated; JNK, c-Jun N-terminal kinase; EGCG, epigallocatechin-3-gallate; IRE1, inositol requiring enzyme 1; ATF-6, activating transcription factor-6; p-PERK, phosphorylated PKR-like ER kinase; eIf2a, eukaryotic translation initiation factor 2 subunit a.
In conclusion, the present study demonstrated that EGCG promotes cell proliferation and apoptosis of high glucose-induced podocytes. Notably, EGCG was observed to suppress high glucose-induced ER stress-induced upregulation of GRP78, p-PERK and caspase-12 protein expression levels. Further study is required to clarify the efficacy of EGCG in the treatment of disease in vivo; however, the results of the present study indicated that it may have potential for the development of a therapeutic drug for DN.
